MRNA
HealthcareModerna, Inc.
$52.38-1.01 (-1.89%)
Prev Close
$53.39
Open
$54.31
High
$55.09
Low
$51.44
Volume
4.85M
Market Cap
$19.96B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Moderna, Inc. (MRNA) has been exclusively selling, with 0 insider purchases totaling $0.00 and 31 insider sales totaling $11.16M. The most recent insider transaction was by Klinger Shannon Thyme (officer: Chief Legal Officer), who sold $726.0K worth of shares on Mar 3, 2026. Moderna, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $19.96B.
Buys (12M)
0
$0.00
Sells (12M)
31
$11.16M
Net Activity
Net Seller
$11.16M
Active Insiders
6
last 12 mo
MRNA Price Chart
MRNA Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 13,885 | $52.29 | $726.0K | 59,689 |
| Feb 25, 2026↗ | Hoge Stephen | officer: President | Sell | 160,009 | $48.84 | $7.81M | 1,457,430 |
| Feb 11, 2026↗ | Bancel Stephane | Chief Executive Officer | Sell | 5,450 | $41.99 | $228.8K | 0 |
| Feb 11, 2026↗ | Hoge Stephen | President | Sell | 2,362 | $41.99 | $99.2K | 0 |
| Feb 11, 2026↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 1,334 | $41.99 | $56.0K | 0 |
| Feb 11, 2026↗ | Mock James M | Chief Financial Officer | Sell | 1,278 | $41.99 | $53.7K | 0 |
| Jan 5, 2026↗ | Mock James M | Chief Financial Officer | Sell | 780 | $30.86 | $24.1K | 0 |
| Dec 11, 2025↗ | AFEYAN NOUBAR | Director | Sell | 23,853 | $29.49 | $703.3K | 0 |
| Dec 9, 2025↗ | Hussain Abbas | Director | Sell | 504 | $27.60 | $13.9K | 0 |
| Dec 5, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 22,817 | $25.49 | $581.6K | 0 |
| Dec 5, 2025↗ | Mock James M | Chief Financial Officer | Sell | 22,817 | $25.49 | $581.6K | 0 |
| Dec 1, 2025↗ | Hoge Stephen | President | Sell | 316 | $25.98 | $8.2K | 0 |
| Dec 1, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 113 | $25.98 | $2.9K | 0 |
| Nov 26, 2025↗ | Hoge Stephen | President | Sell | 990 | $24.83 | $24.6K | 0 |
| Nov 26, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 534 | $24.83 | $13.3K | 0 |
| Nov 26, 2025↗ | Mock James M | Chief Financial Officer | Sell | 534 | $24.83 | $13.3K | 0 |
| Oct 3, 2025↗ | Mock James M | Chief Financial Officer | Sell | 703 | $28.37 | $19.9K | 0 |
| Aug 29, 2025↗ | Hoge Stephen | President | Sell | 315 | $24.47 | $7.7K | 0 |
| Aug 29, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 113 | $24.47 | $2.8K | 0 |
| Aug 27, 2025↗ | Hoge Stephen | President | Sell | 991 | $24.84 | $24.6K | 0 |
| Aug 27, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 535 | $24.84 | $13.3K | 0 |
| Aug 27, 2025↗ | Mock James M | Chief Financial Officer | Sell | 535 | $24.84 | $13.3K | 0 |
| Jul 3, 2025↗ | Mock James M | Chief Financial Officer | Sell | 703 | $30.28 | $21.3K | 0 |
| Jun 11, 2025↗ | Hussain Abbas | Director | Sell | 312 | $28.00 | $8.7K | 0 |
| Jun 6, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 551 | $26.12 | $14.4K | 0 |
| May 30, 2025↗ | Hoge Stephen | President | Sell | 316 | $26.93 | $8.5K | 0 |
| May 30, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 113 | $26.93 | $3.0K | 0 |
| May 27, 2025↗ | Hoge Stephen | President | Sell | 990 | $26.41 | $26.1K | 0 |
| May 27, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 533 | $26.41 | $14.1K | 0 |
| May 27, 2025↗ | Mock James M | Chief Financial Officer | Sell | 533 | $26.41 | $14.1K | 0 |
| Apr 4, 2025↗ | Mock James M | Chief Financial Officer | Sell | 703 | $25.73 | $18.1K | 0 |
| Mar 7, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 551 | $34.30 | $18.9K | 0 |
| Mar 3, 2025↗ | Bancel Stephane | Chief Executive Officer | Buy | 160,314 | $31.22 | $5.00M | 0 |
| Mar 3, 2025↗ | SAGAN PAUL | Director | Buy | 31,620 | $31.76 | $1.00M | 0 |
| Feb 28, 2025↗ | Hoge Stephen | President | Sell | 612 | $31.09 | $19.0K | 0 |
| Feb 28, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 273 | $31.09 | $8.5K | 0 |
| Feb 28, 2025↗ | Mock James M | Chief Financial Officer | Sell | 160 | $31.09 | $5.0K | 0 |
| Feb 27, 2025↗ | Hoge Stephen | President | Sell | 2,779 | $33.58 | $93.3K | 0 |
| Feb 27, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 2,779 | $33.58 | $93.3K | 0 |
| Feb 27, 2025↗ | Mock James M | Chief Financial Officer | Sell | 2,780 | $33.58 | $93.4K | 0 |
MRNA Insider Buying Activity
The following table shows recent insider purchases of Moderna, Inc. (MRNA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2025↗ | Bancel Stephane | Chief Executive Officer | Buy | 160,314 | $31.22 | $5.00M | 0 |
| Mar 3, 2025↗ | SAGAN PAUL | Director | Buy | 31,620 | $31.76 | $1.00M | 0 |
MRNA Insider Selling Activity
The following table shows recent insider sales of Moderna, Inc. (MRNA) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026↗ | Klinger Shannon Thyme | officer: Chief Legal Officer | Sell | 13,885 | $52.29 | $726.0K | 59,689 |
| Feb 25, 2026↗ | Hoge Stephen | officer: President | Sell | 160,009 | $48.84 | $7.81M | 1,457,430 |
| Feb 11, 2026↗ | Bancel Stephane | Chief Executive Officer | Sell | 5,450 | $41.99 | $228.8K | 0 |
| Feb 11, 2026↗ | Hoge Stephen | President | Sell | 2,362 | $41.99 | $99.2K | 0 |
| Feb 11, 2026↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 1,334 | $41.99 | $56.0K | 0 |
| Feb 11, 2026↗ | Mock James M | Chief Financial Officer | Sell | 1,278 | $41.99 | $53.7K | 0 |
| Jan 5, 2026↗ | Mock James M | Chief Financial Officer | Sell | 780 | $30.86 | $24.1K | 0 |
| Dec 11, 2025↗ | AFEYAN NOUBAR | Director | Sell | 23,853 | $29.49 | $703.3K | 0 |
| Dec 9, 2025↗ | Hussain Abbas | Director | Sell | 504 | $27.60 | $13.9K | 0 |
| Dec 5, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 22,817 | $25.49 | $581.6K | 0 |
| Dec 5, 2025↗ | Mock James M | Chief Financial Officer | Sell | 22,817 | $25.49 | $581.6K | 0 |
| Dec 1, 2025↗ | Hoge Stephen | President | Sell | 316 | $25.98 | $8.2K | 0 |
| Dec 1, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 113 | $25.98 | $2.9K | 0 |
| Nov 26, 2025↗ | Hoge Stephen | President | Sell | 990 | $24.83 | $24.6K | 0 |
| Nov 26, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 534 | $24.83 | $13.3K | 0 |
| Nov 26, 2025↗ | Mock James M | Chief Financial Officer | Sell | 534 | $24.83 | $13.3K | 0 |
| Oct 3, 2025↗ | Mock James M | Chief Financial Officer | Sell | 703 | $28.37 | $19.9K | 0 |
| Aug 29, 2025↗ | Hoge Stephen | President | Sell | 315 | $24.47 | $7.7K | 0 |
| Aug 29, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 113 | $24.47 | $2.8K | 0 |
| Aug 27, 2025↗ | Hoge Stephen | President | Sell | 991 | $24.84 | $24.6K | 0 |
| Aug 27, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 535 | $24.84 | $13.3K | 0 |
| Aug 27, 2025↗ | Mock James M | Chief Financial Officer | Sell | 535 | $24.84 | $13.3K | 0 |
| Jul 3, 2025↗ | Mock James M | Chief Financial Officer | Sell | 703 | $30.28 | $21.3K | 0 |
| Jun 11, 2025↗ | Hussain Abbas | Director | Sell | 312 | $28.00 | $8.7K | 0 |
| Jun 6, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 551 | $26.12 | $14.4K | 0 |
| May 30, 2025↗ | Hoge Stephen | President | Sell | 316 | $26.93 | $8.5K | 0 |
| May 30, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 113 | $26.93 | $3.0K | 0 |
| May 27, 2025↗ | Hoge Stephen | President | Sell | 990 | $26.41 | $26.1K | 0 |
| May 27, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 533 | $26.41 | $14.1K | 0 |
| May 27, 2025↗ | Mock James M | Chief Financial Officer | Sell | 533 | $26.41 | $14.1K | 0 |
| Apr 4, 2025↗ | Mock James M | Chief Financial Officer | Sell | 703 | $25.73 | $18.1K | 0 |
| Mar 7, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 551 | $34.30 | $18.9K | 0 |
| Feb 28, 2025↗ | Hoge Stephen | President | Sell | 612 | $31.09 | $19.0K | 0 |
| Feb 28, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 273 | $31.09 | $8.5K | 0 |
| Feb 28, 2025↗ | Mock James M | Chief Financial Officer | Sell | 160 | $31.09 | $5.0K | 0 |
| Feb 27, 2025↗ | Hoge Stephen | President | Sell | 2,779 | $33.58 | $93.3K | 0 |
| Feb 27, 2025↗ | Klinger Shannon Thyme | Chief Legal Officer | Sell | 2,779 | $33.58 | $93.3K | 0 |
| Feb 27, 2025↗ | Mock James M | Chief Financial Officer | Sell | 2,780 | $33.58 | $93.4K | 0 |
MRNA Insiders
Similar Stocks to MRNA
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$538.00+0.97%
$21.50B
INCY
Incyte Corporation
$92.25+0.27%
$20.10B
RVMD
Revolution Medicines, Inc.
$95.44+0.39%
$20.10B
ROIV
Roivant Sciences Ltd.
$28.14-1.44%
$19.80B